BUZZ-Valeant Pharmaceuticals International Inc: Hits record high
** Canadian drugmaker's U.S.-listed shares up about 4.2 pct at $249 after hitting record high of $252.79
** Toronto-listed stock rises 5.6 pct to hit record high of C$330
** Reports better-than-expected quarterly profit, helped by strength in its U.S. dermatology business
** Raises 2015 forecast to reflect sales of recently acquired Salix Pharmaceuticals' irritable bowel syndrome drug, Xifaxan
** Up to Wednesday's close, U.S-listed stock had risen about 21 pct since March 16, when Valeant trumped Endo International Plc for Salix
© Thomson Reuters 2017 All rights reserved.